China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$3.05 +0.04 (+1.33%)
As of: Oct 1, 2026 · 11:59 AM EDT

China SXT Pharmaceuticals (SXTC) Current Debt (2018 - 2019)

Updated

China SXT Pharmaceuticals' Current Debt came in at -$224,872 for FY2020 (year ended Mar 31, 2020), compared with -$127,034 in FY2019.

Analysis

China SXT Pharmaceuticals (SXTC) Current Debt (2018 - 2019) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Current Debt at -$127,034 in FY2019 and $365,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 37.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 China SXT Pharmaceuticals 39,500.23 -85.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -127,034.00
Dec 31, 2018 365,000.00
API Access

China SXT Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=SXTC&period=max&api_key=YOUR_API_KEY